News

The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...
European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...
Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...
Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.
NextCure has entered a strategic partnership with Simcere Zaiming, to develop SIM0505, a new ADC targeting CDH6 for treating ...
After Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.